3,6,9,12,15,18,21,24,27,30-Decaoxadotetracontan-1-ol (CED0186664)

Record Information
Version1.0
Creation Date2026-04-02 22:51:25 UTC
Update Date2026-08-22 11:05:16 UTC
Accession NumberCHEM058856
Identification
Common Name3,6,9,12,15,18,21,24,27,30-Decaoxadotetracontan-1-ol
ClassSmall Molecule
Description
3,6,9,12,15,18,21,24,27,30-Decaoxadotetracontan-1-ol belongs to the ethers, a subclass of organooxygen compounds within the organic compounds. With an average molecular weight of 626.87 g/mol, 3,6,9,12,15,18,21,24,27,30-Decaoxadotetracontan-1-ol is a heavy molecule. This compound has the chemical formula C32H66O11. In industrial applications, it is utilized as a surfactant, a dispersing agent, and a non-aqueous wetting agent. Regarding its environmental presence, it has been recorded in indoor air, dust, and atmospheric transport. The recorded route of exposure for this substance is inhalation.
Contaminant TypeNot Available
Chemical Structure
MOLSDFPDBSMILESInChI
SynonymsNot Available
Chemical FormulaC32H66O11
Average Molecular Mass626.869 g/mol
Monoisotopic Mass626.461 g/mol
CAS Registry Number6540-99-4
IUPAC NameNot Available
Traditional NameNot Available
SMILESCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO
InChI IdentifierInChI=1S/C32H66O11/c1-2-3-4-5-6-7-8-9-10-11-13-34-15-17-36-19-21-38-23-25-40-27-29-42-31-32-43-30-28-41-26-24-39-22-20-37-18-16-35-14-12-33/h33H,2-32H2,1H3
InChI KeyKOMQWDINDMFMPD-UHFFFAOYSA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
SpectraNot Available
Toxicity Profile
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Toxicity ValuesNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
19Indoor airAir, dust & atmospheric transportNot Available
490Personal care & cosmeticsNot Available
Pathways
0 pathways

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Click to view 3D structurePhospholipase BQ9P8P2Cryptococcus neoformansPredicted (SEA)0.467095
Click to view 3D structureFatty-acid amide hydrolase 1P97612Rattus norvegicusPredicted (SEA)66.6389
Peroxisome proliferator-activated receptor alpha structureClick to view 3D structurePeroxisome proliferator-activated receptor alphaQ07869HumansPredicted (SEA)101.593
Click to view 3D structureJuvenile hormone esteraseQ9GPG0Manduca sextaPredicted (SEA)2.49118
Tyrosine-protein phosphatase non-receptor type 1 structureClick to view 3D structureTyrosine-protein phosphatase non-receptor type 1P18031HumansPredicted (SEA)85.5563
Click to view 3D structureFatty-acid amide hydrolase 1O00519HumansPredicted (SEA)131.565
Liver carboxylesterase 1 structureClick to view 3D structureLiver carboxylesterase 1P23141HumansPredicted (SEA)23.8997
Peroxisome proliferator-activated receptor delta structureClick to view 3D structurePeroxisome proliferator-activated receptor deltaQ03181HumansPredicted (SEA)90.3829
Click to view 3D structureCannabinoid receptor 1P20272Rattus norvegicusPredicted (SEA)60.0996
G-protein coupled receptor 84 structureClick to view 3D structureG-protein coupled receptor 84Q9NQS5HumansPredicted (SEA)9.88685
Click to view 3D structureNon-lysosomal glucosylceramidaseQ9HCG7HumansPredicted (SEA)1.47914
Click to view 3D structureCeramide glucosyltransferaseO88693Mus musculusPredicted (SEA)1.32344
Click to view 3D structureSodium- and chloride-dependent creatine transporter 1P28570Rattus norvegicusPredicted (SEA)0.233548
Click to view 3D structureAcylcarnitine hydrolaseQ91WG0Mus musculusPredicted (SEA)0.311397
Click to view 3D structureSucrase-isomaltaseB5THE3Mus musculusPredicted (SEA)1.24559
Click to view 3D structurePutative inactive group IIC secretory phospholipase A2Q5R387HumansPredicted (SEA)1.16774
UDP-3-O-acyl-N-acetylglucosamine deacetylase structureClick to view 3D structureUDP-3-O-acyl-N-acetylglucosamine deacetylaseO67648Aquifex aeolicus (strain VF5)Predicted (SEA)19.618
Lysosomal acid glucosylceramidase structureClick to view 3D structureLysosomal acid glucosylceramidaseP04062HumansPredicted (SEA)3.11397
Click to view 3D structureLysosomal alpha-glucosidaseP70699Mus musculusPredicted (SEA)1.63483
Click to view 3D structureCocaine esteraseO00748HumansPredicted (SEA)3.65891
Click to view 3D structureCG8425-PA [Drosophila melanogaster]A1ZA98Drosophila melanogasterPredicted (SEA)1.63483
Click to view 3D structureLiver carboxylesteraseQ29550Sus scrofaPredicted (SEA)2.10193
Click to view 3D structureTransient receptor potential cation channel subfamily V member 2Q9WUD2Rattus norvegicusPredicted (SEA)13.8572
Lysophosphatidic acid receptor 2 structureClick to view 3D structureLysophosphatidic acid receptor 2Q9HBW0HumansPredicted (SEA)7.31783
Click to view 3D structureLysophosphatidic acid receptor 3Q9UBY5HumansPredicted (SEA)8.56341
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available